210 related articles for article (PubMed ID: 34983605)
1. Usefulness of random-start progestin-primed ovarian stimulation for fertility preservation.
Huang H; Itaya Y; Samejima K; Ichinose S; Narita T; Matsunaga S; Saitoh M; Takai Y
J Ovarian Res; 2022 Jan; 15(1):2. PubMed ID: 34983605
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation.
Zhao W; Sun P; Li T; Li Y; Liang X; Li J
Int J Gynaecol Obstet; 2023 Nov; 163(2):645-650. PubMed ID: 37265085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
4. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
Shi Z; Zhao W; Wu X; Bi X
Gynecol Endocrinol; 2024 May; 40(1):2352133. PubMed ID: 38749017
[TBL] [Abstract][Full Text] [Related]
6. Oocyte competence is comparable between progestin primed ovarian stimulation with Norethisterone acetate (NETA-PPOS) and GnRH-antagonist protocols: A matched case-control study in PGT-A cycles.
Vaiarelli A; Cimadomo D; Ruffa A; Rania E; Pittana E; Gallo C; Fiorenza A; Alviggi E; Alfano S; Carmelo R; Trabucco E; Alviggi C; Rosaria Campitiello M; Rienzi L; Maria Ubaldi F; Venturella R
Eur J Obstet Gynecol Reprod Biol; 2024 Mar; 294():4-10. PubMed ID: 38171151
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of fertility preservation in women with endometriosis: comparison of progestin-primed ovarian stimulation versus antagonist protocols.
Mathieu d'Argent E; Ferrier C; Zacharopoulou C; Ahdad-Yata N; Boudy AS; Cantalloube A; Levy R; Antoine JM; Daraï E; Bendifallah S
J Ovarian Res; 2020 Feb; 13(1):18. PubMed ID: 32054493
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis.
Duc Thang L; Bao Long H; Thi Thu Trang D; Ngoc Quy P; Thi Mai Phuong G; Thi Hanh B; Trong Thach T; Thi Lien Huong N; Hoang L; Hugues JN
J Formos Med Assoc; 2024 Apr; 123(4):523-529. PubMed ID: 38092654
[TBL] [Abstract][Full Text] [Related]
9. Progestin primed ovarian stimulation using dydrogesterone from day 7 of the cycle onwards in oocyte donation cycles: a longitudinal study.
Hendrickx S; De Vos M; De Munck N; Mackens S; Ruttens S; Tournaye H; Blockeel C
Reprod Biomed Online; 2024 May; 48(5):103732. PubMed ID: 38458058
[TBL] [Abstract][Full Text] [Related]
10. Medroxyprogesterone acetate: an alternative to GnRH-antagonist in oocyte vitrification for social fertility preservation and preimplantation genetic testing for aneuploidy.
Giles J; Cruz M; Cobo A; Vidal C; Requena A; Remohi J; Bosch E
Reprod Biomed Online; 2023 Aug; 47(2):103222. PubMed ID: 37290978
[TBL] [Abstract][Full Text] [Related]
11. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval.
Kao TC; Hsieh YC; Yang IJ; Wu MY; Chen MJ; Yang JH; Chen SU
J Formos Med Assoc; 2023 Jan; 122(1):29-35. PubMed ID: 36123235
[TBL] [Abstract][Full Text] [Related]
12. Progesterone-primed ovarian stimulation in oocyte donation: a model for elective fertility preservation?
Devesa M; Racca A; Clúa E; Casato C; García S; Polyzos NP; Martínez F
Reprod Biomed Online; 2022 Jun; 44(6):1015-1022. PubMed ID: 35339364
[TBL] [Abstract][Full Text] [Related]
13. Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series.
Russo M; Liu K; Chan C
Reprod Biol Endocrinol; 2020 Jun; 18(1):59. PubMed ID: 32503566
[TBL] [Abstract][Full Text] [Related]
14. Comparison of euploidy rates of blastocysts in women treated with progestins or GnRH antagonist to prevent the luteinizing hormone surge during ovarian stimulation.
La Marca A; Capuzzo M; Sacchi S; Imbrogno MG; Spinella F; Varricchio MT; Minasi MG; Greco P; Fiorentino F; Greco E
Hum Reprod; 2020 Jun; 35(6):1325-1331. PubMed ID: 32395749
[TBL] [Abstract][Full Text] [Related]
15. Should the trigger to oocyte retrieval interval be different in progestin-primed ovarian stimulation cycles?
Ata B; Cakar A; Türkgeldi E; Yildiz S; Keles İ; Kalafat E
Reprod Biomed Online; 2024 Feb; 48(2):103626. PubMed ID: 38160486
[TBL] [Abstract][Full Text] [Related]
16. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
17. Progestin-primed ovarian stimulation for fertility preservation in women with cancer: A comparative study.
Filippi F; Reschini M; Polledri E; Cecchele A; Guarneri C; Vigano P; Fustinoni S; Platteau P; Somigliana E
PLoS One; 2023; 18(3):e0280238. PubMed ID: 36976781
[TBL] [Abstract][Full Text] [Related]
18. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
Zhang S; Yin Y; Li Q; Zhang C
Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
[TBL] [Abstract][Full Text] [Related]
20. Progestin-Primed Ovarian Stimulation Versus Mild Stimulation Protocol in Advanced Age Women With Diminished Ovarian Reserve Undergoing Their First
Tu X; You B; Jing M; Lin C; Zhang R
Front Endocrinol (Lausanne); 2021; 12():801026. PubMed ID: 35140685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
